1. India Stocks

  2. •

    Consumer Defensive

  3. •

    Food Distribution
Unjha Formulations Limited

Unjha Formulations Limited

UNJHAFOR.BO
Unjha Formulations LimitedIN flagBombay Stock Exchange
19.50
INR
+0.95
- -
87.37MMarket Cap
Unjha Formulations Limited
UNJHAFOR.BO
(Bombay Stock Exchange)

Recent

price

19.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
9.85
13.18
11.12
14.94
20.05
22.96
27.34
25.38
25.49
23.72
22.11
31.41
29.33
41.26
30.95
- -
35.03
Revenue per Share
0.26
0.18
0.2
0.28
0.39
0.57
0.66
0.59
0.67
0.69
0.23
0.56
0.63
0.62
0.91
- -
1.58
Basic EPS, GAAP
- -
4.53
1.07
0.9
-1.77
0.86
0.23
0.3
-0.27
0.65
-1.71
0.82
-0.8
2.05
-0.5
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.36
-0.19
0.05
0.44
1
1.67
2.27
2.93
3.62
3.83
5.44
5.47
6.09
7.01
- -
10.07
Book Value per Share
- -
-1.04
-0.87
-0.64
-0.25
0.33
0.99
1.59
2.25
2.94
3.15
4.33
4.36
4.98
5.89
- -
7.51
Tangible Book Value per Share
4
4
4
4
4
5
4
4
4
4
5
5
4
4
4
- -
4
Basic Weighted Avg Shares
44
59
50
66
89
104
122
113
114
106
100
142
132
185
139
156
156
Sales/Revenue/Turnover
3.07
1.53
1.94
1.95
1.78
3.36
2.37
2.32
3.91
1.71
2.41
1.8
2.71
2.67
3.84
6.17
5.77
Operating Margin (%)
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Depreciation Expense
1
1
1
1
2
3
3
3
3
3
1
3
3
3
4
7
7
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
15.72
14.29
38.49
22.15
26.12
26.12
Effective Tax Rate (%)
2.64
1.38
1.83
1.87
1.94
2.48
2.41
2.32
2.63
2.91
1.04
1.78
2.15
1.5
2.94
4.52
4.52
Profit Margin (%)
- -
-13
-12
-11
-9
-6
-5
-2
4
7
8
14
14
16
19
25
25
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
1
2
4
6
9
12
15
18
19
25
25
27
31
38
38
Total Equity
- -
60.43
47.07
78.79
31.54
48.41
35.42
23.87
32.93
10.93
12.84
9.81
12.38
11.62
14
20.33
19.02
Return on Invested Capital (%)
- -
173.82
973.7
-415.94
57.3
66.54
61.46
29.67
26.28
28.62
15.91
17.43
13.13
11.94
14.1
18.65
18.65
Return on Capital (%)
- -
- -
- -
- -
159.57
79.31
49.19
29.84
25.86
21.04
6.19
12.09
11.52
10.72
13.89
18.5
18.5
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
- -
4
Market Capitalization
113
111
90

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
52
- -
42
Cash, Cash Equivalents & STI
16
- -
16
Accounts Receivable, Net
19
- -
13
Inventories
14
- -
6
Total Current Liabilities
21
- -
17
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
22.45%
Free Cash Flow
-230.81%
-274.36%
-546.81%
Net Income, GAAP
22.8%
54.73%
72.89%
Sales/Revenue/Turnover
6.13%
12.63%
12.43%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
38
48
55
44
185
2025
40
38
38
24
139
2026
36
43
44
33
156

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.4
-0.26
0.87
- -
0.62
2025
1.56
-0.25
0.5
-0.91
0.91
2026
0.9
1.83
0.53
-1.66
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Integra Essentia Limited (ESSENTIA.BO)
China Starch Holdings Limited (3838.HK)
Red Oak Hereford Farms, Inc. (HERF)
Saudia Dairy & Foodstuff Company (2270.SR)
Norway Royal Salmon AS (NRS.OL)
Medicale Corp (MCLE)
Business
Unjha Formulations Limited manufactures and sells ayurvedic products, specializing in Isabgol (psyllium) formulations, in India. The company offers sat-isabgol and isabgol husk in elaichi flavor under the Anchor brand; isabgol powder in orange flavor under the Fibron and Fibron SF brands; and additional pharmaceutical formulations including liquids, powders, tablets, capsules, and injectibles for human consumption and veterinary use. It operates a GMP-certified facility focused on hygienic sat-isabgol, isabgol husk, and natural fibre drinks, with exports to international markets. Founded in 1991 and headquartered in Sidhpur, Gujarat, the company serves the healthcare pharmaceuticals and biotechnology segment, targeting consumers seeking ayurvedic remedies for digestive health and related conditions. It functions as part of M/s Urvesh Ltd., a parent entity engaged in exporting isabgol husk and powder as a 100% export-oriented unit. Operations emphasize quality control through physico-chemical and microbiological testing at its modern plant. In recent developments, Unjha Formulations reported positive financial results for Q2 fiscal 2024-2025, with increased profit after tax and higher operating cash flow despite lower PBDIT and PBT; it held its 31st annual general meeting on August 13, 2025, approving all resolutions unanimously and appointing Ajay Parikh & Associates as secretarial auditor for fiscal 2025-26 through 2029-30. The company submitted updated financial statements, including balance sheet, P&L, and cash flow as of March 31, 2025, in compliance with SEBI regulations, and filed its distribution schedule post-AGM. It maintains a low-debt profile with ROCE at 18.1% and focuses on domestic expansion amid modest sales growth.